New research has found that the future success of adolescents who use amphetamines and marijuana will not be adversely affected if they quit the habit before hitting age 30. The study found that people who stopped using these drugs in early adulthood didn’t have lower life quality or relationship or economic success.
The authors of the study explained that amphetamine and marijuana use and/or use disorder in adolescence didn’t appear to doom life success for individuals in adulthood, particularly for those who ceased using the drugs before the age of 30.
The findings of this study were published I”n Addiction Research & Theory.”
The researchers’ study objective was to find the extent to which the use of amphetamines and marijuana up to age 21 forecasted life success for an individual at age 30. Onset use in those who took part in the study ranged between 15 and 19 years.
For their study, the researchers utilized data from more than 2,300 children in Australia who were born to mothers who took part in the Mater-University of Queensland pregnancy study. These children were tested for delinquency/aggression, mental health and IQ at age 14. They were also interviewed at 21, where they self-reported their use of amphetamines and marijuana. They self-reported their use once more at age 30.
Researchers also carried out a composite measure of life success at age 30. This measure considered quality of intimate relationships, quality of life and socioeconomic status. Their findings showed that at 21 years, problematic marijuana use was lower at 18%, with 3% admitting to problematic use of both marijuana and amphetamines and 0.8% reporting only problematic amphetamine use.
With regard to those who reported problematic substance use, these issues persisted at age 30 for 60% of those on both marijuana and amphetamines and more than 35% of those who used marijuana.
In their report, the researchers noted that behavior problems in adolescence predicted drug use at age 21 as well as life success and drug use at age 30. The researchers also discovered a link between early-age onset use of amphetamines, marijuana or both, noting that concurrent use of marijuana at the age 30 follow up was strongly associated with life success.
In their report, the researchers also argued that prior research, which suggested that early-age onset of using these substances led to adverse outcomes when an individual was older, didn’t consider the possibility that it was the subsequent use of drugs which forecasted success in adult life.
As more research is conducted on actual products manufactured by licensed companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), many more misconceptions about the herb may be unveiled.
NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.